# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
New York-based Pfizer currently has a dividend yield of 5.96% — a quarterly dividend of 42 cents a share ($1.68 a year).
An unprecedented 60% of patients remain alive without disease progression after five yearsUpdated results show continued 81% re...
Mass retirement of boomers could have major economic impact. Experts anticipate both risks and opportunities from the largest w...
RBC Capital Markets downgrades Sarepta Therapeutics following increased FDA label expansion expectations for Elevidys and recen...
Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter...
Chicago jury rejects woman's claim that Zantac caused her colon cancer. First of thousands of similar lawsuits, companies d...